Insider Selling: Intuitive Surgical (NASDAQ:ISRG) EVP Sells 400 Shares of Company Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Gary Loeb sold 400 shares of the stock in a transaction that occurred on Tuesday, November 10th. The shares were sold at an average price of $458.15, for a total value of $183,260.00. Following the transaction, the executive vice president owned 6,236 shares of the company’s stock, valued at $2,857,023.40. This represents a 6.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $449.53 on Thursday. The stock has a market capitalization of $155.83 billion, a PE ratio of 54.36, a P/E/G ratio of 3.10 and a beta of 1.45. The company’s fifty day moving average is $414.76 and its 200 day moving average is $430.83. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The business had revenue of $3.05 billion during the quarter, compared to analyst estimates of $2.91 billion. During the same quarter last year, the business earned $2.40 earnings per share. Intuitive Surgical’s quarterly revenue was up 21.7% compared to the same quarter last year. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the company. Dogwood Wealth Management LLC lifted its holdings in Intuitive Surgical by 178.3% in the third quarter. Dogwood Wealth Management LLC now owns 64 shares of the medical equipment provider’s stock valued at $26,000 after acquiring an additional 41 shares during the period. North Point Portfolio Managers Corp OH acquired a new position in shares of Intuitive Surgical in the third quarter worth about $27,000. John Boyer Inc. purchased a new stake in shares of Intuitive Surgical during the 3rd quarter worth about $27,000. Compass Wealth Management LLC acquired a new stake in shares of Intuitive Surgical during the 3rd quarter valued at about $29,000. Finally, Main Street Group LTD purchased a new position in shares of Intuitive Surgical in the 1st quarter valued at about $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms recently commented on ISRG. Oppenheimer reiterated an “outperform” rating and issued a $500.00 price target on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Stifel Nicolaus decreased their price objective on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a research report on Friday, July 17th. BMO Capital Markets reaffirmed an “outperform” rating on shares of Intuitive Surgical in a research note on Monday, July 20th. Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, October 31st. Finally, TD Cowen restated a “buy” rating and set a $485.00 price objective on shares of Intuitive Surgical in a report on Monday, October 19th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $493.54.

About Intuitive Surgical

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.